Results 21 to 30 of about 17,928 (186)

Refinement and preliminary evaluation of two tablet-based tests of real-world visual function [PDF]

open access: yes, 2019
PURPOSE: To describe, refine, evaluate, and provide normative control data for two freely available tablet-based tests of real-world visual function, using a cohort of young, normally-sighted adults.
Bi, W.   +6 more
core   +2 more sources

Clinical image: Rare photographic documentation of uveal melanoma progression

open access: yesAmerican Journal of Ophthalmology Case Reports, 2022
Purpose: To present clinical images of a patient with neovascular glaucoma and hypermature cataract masking orbital extension of a uveal melanoma. Observations: A 67-year-old female was referred for neovascular glaucoma and found to have an intraocular ...
Colin Bacorn, Esther Kim, Lily Koo Lin
doaj   +1 more source

Cyclophotocoagulation with diode laser in refractory glaucoma, long-term results [PDF]

open access: yes, 2003
PURPOSE: To report long-term experience with cyclophotocoagulation using diode laser in refractory glaucomas. METHODS: We selected cases of refractory glaucoma with indication for cyclophotocoagulation (CPC) with diode laser using a G probe (Iris Medical)
Lima, Vera Christina Waller de   +2 more
core   +3 more sources

Large choroidal melanoma presenting as neovascular glaucoma

open access: yesGMS Ophthalmology Cases, 2019
Choroidal melanoma is a relatively rare tumour with a poor prognosis, though it is the most common primary malignancy of the eye among adults. Choroidal melanoma has been reported to present as acute angle closure glaucoma, secondary glaucoma, chronic ...
Sahu, Sabin   +4 more
doaj   +1 more source

Modified Schocket implant for refractory glaucoma: long-term results [PDF]

open access: yes, 2000
Purpose: To analyze long-term results of modified Schocket implant. Methods: The records of 45 patients (45 surgeries) with at least one year follow-up who received a modified Schocket implant were analyzed. Comparisons were made regarding success rates (
Omi, Carlos Akira   +2 more
core   +3 more sources

RISK FACTORS FOR DEVELOPMENT OF NEOVASCULAR GLAUCOMA AFTER MINIINVASIVE DIABETIC VITRECTOMY IN PATIENTS WITH POLIFERATIVE DIABETIC RETINOPATHY

open access: yesMedična Informatika ta Inženerìâ, 2015
The article presents the risk factors for neovascular glaucoma in patients after miniinvasive diabetic vitrectomy. This was a retrospective study of 237 eyes (237 patients) who underwent combined sutureless vitrectomy 23/25G for the complications of ...
A. N. Ruban
doaj   +1 more source

Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study. [PDF]

open access: yes, 2013
BACKGROUND: Diseases of the posterior segment of the eye, including age-related macular degeneration (AMD), have recently been recognised as the leading or second leading cause of blindness in several African countries.
Bastawrous, Andrew   +5 more
core   +6 more sources

Rapidly progressive neovascular glaucoma following coronary artery bypass graft surgery in a patient with type 1 diabetes mellitus: a case report

open access: yesJournal of Medical Case Reports, 2018
Background Proliferative diabetic retinopathy leading to vitreous hemorrhage, tractional retinal detachment, and neovascular glaucoma is a major cause of severe sight impairment in adults of working age worldwide.
Vasant Raman, Rosemary Lambley
doaj   +1 more source

Longer-term Baerveldt to Trabectome glaucoma surgery comparison using propensity score matching [PDF]

open access: yes, 2017
Purpose: To apply propensity score matching to compare Baerveldt glaucoma drainage implant (BGI) to Trabectome-mediated ab interno trabeculectomy (AIT). Recent data suggests that AIT can produce results similar to BGI which is traditionally reserved for ...
Brown, EN   +6 more
core   +1 more source

Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma [PDF]

open access: yes, 2016
The approval of one of the first anti-vascular endothelial growth factor (VEGF) agents for the treatment of neovascular age-related macular degeneration one decade ago marked the beginning of a new era in the management of several sight-threatening ...
Andrés Guerrero, Vanessa   +9 more
core   +4 more sources

Home - About - Disclaimer - Privacy